Across TCGA pan-cancer cohorts, PPIL1P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of PPIL1P1’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where PPIL1P1 RNA is repressed in tumor relative to normal tissue. In most cancer types PPIL1P1 is over-expressed in tumor, although a few such as LUAD and THCA show the opposite, repressed pattern.
LUAD, THCA, and KIRC are the cancer types where PPIL1P1 tumor–normal differential expression is most reproducible.